Post-authorisation study to evaluate the effectiveness of the risk minimisation activities in the treatment of SPAF (Risk minimisation in SPAF)

First published 27/03/2015

Last updated 16/10/2026

EU PAS number:

EUPAS9111

Study

Finalised

Download as PDF

Documents

Study protocol

No information provided.

Study results

1160-0149_Post Authorisation Study_marked_Redacted

English (878.21 KB - PDF) View document

1160-0149_Synopsis.pdf

English (245.51 KB - PDF) View document

Study report

No information provided.

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

No information provided.

Post-authorisation study to evaluate the effectiveness of the risk minimisation activities in the treatment of SPAF (Risk minimisation in SPAF)

Secondary tabs

Share this page